U.S. scientists are racing to save the Tasmanian devil from extinction from a unique, transmissible and rapidly spreading cancer.
The process by which the cancer spreads -- physical contact -- has only been seen once before and represents a new field in cancer biology. Once an animal is afflicted, tumors appear on its face and neck, restricting the ability to eat. Within approximately three months, the devils succumb to the disease, often through starvation. Officials project that within 20 years the species could become extinct.
Researchers at Cold Spring Harbor Laboratory, led by native Tasmanian Elizabeth Murchison, are attempting to determine how the tumors work at a molecular level.
"Once the cancer genes are fully sequenced, we will have a better chance to identify the cause and genetic makeup of this unique cancer," said Murchison.
The uniqueness of the tumor structure also has human implications.
"We're using all of the research tools employed for understanding human tumor biology," said Gregory Hannon, a Howard Hughes Medical Institute investigator who oversees Murchison's work. "A cure for the devil may have applications for humans as well."
Copyright 2008 by United Press International
Related stories:
Tasmanian devils face extinction
Australian scientists say the ongoing fight to save Tasmanian devils from extinction may be doomed.
Canine cancer found transmissible
Scientists in England have discovered that when it comes to man's best friend, the age-old wisdom that you can't catch cancer isn't true.
Study: Tasmanian Devil may face extinction
A rare cancer is reportedly decimating Australia's dwindling Tasmanian Devil population, ABC News reported Thursday.
Cancer is threatening Tasmanian devils
Australian scientists say a deadly facial-tumor disease threatening a carnivorous Australian marsupial known as the Tasmanian devil might be infectious.
Parsing the genome of a deadly brain tumor
The most comprehensive to-date genomic analysis of a cancer – the deadly brain tumor glioblastoma multiforme – shows previously unrecognized changes in genes and provides an overall view of the missteps in the pathways that govern the growth and behavior of cells, said members of The Cancer Genome Atlas Research Network in a report that appears online today in the journal
Nature.
1 step back ... 2 steps forward
Women with hormone-receptor positive, metastatic breast cancer may take medications for years to help keep their cancer at bay, but when the tumor becomes resistant to anti-hormonal drugs, treatment with chemotherapy becomes the only option. But a study presented today at the 2008 ASCO Breast Cancer Symposium may change this approach. Early data suggests a new treatment approach can "re-sensitize" the tumor, allowing anti-hormonal drugs to do their job once again.
Atomic structure of the mammalian 'fatty acid factory' determined
Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. Now researchers at ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase. Their results have just been published in
Science magazine.
Studies spot numerous undiscovered gene alterations in pancreatic and brain cancers
HHMI investigators have detected a multitude of broken, missing, and overactive genes in pancreatic and brain tumors, in the most detailed genetic survey yet of any human tumor. Some of these genetic changes were previously unknown and could provide new leads for improved diagnosis and therapy for these devastating cancers.